{"id":"NCT01908140","sponsor":"AstraZeneca","briefTitle":"Study of Aclidinium Bromide/Formoterol Fumarate Compared With Salmeterol/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)","officialTitle":"A Randomised, Double-blind, Double-dummy, Active-controlled Study Evaluating the Efficacy, Safety and Tolerability of Twice-daily Aclidinium Bromide/Formoterol Fumarate Compared With Twice-daily Salmeterol/Fluticasone Propionate for 24 Weeks Treatment in Symptomatic Patients With Chronic Obstructive Pulmonary Disease (COPD)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-09","primaryCompletion":"2014-08","completion":"2014-08","firstPosted":"2013-07-25","resultsPosted":"2016-03-07","lastUpdate":"2016-03-07"},"enrollment":933,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Obstructive Pulmonary Disease (COPD)"],"interventions":[{"type":"DRUG","name":"Aclidinium Bromide / Formoterol Fumarate","otherNames":[]},{"type":"DRUG","name":"Salmeterol / Fluticasone","otherNames":["Seretide","Advair"]}],"arms":[{"label":"Aclidinium Bromide / Formoterol Fumarate","type":"EXPERIMENTAL"},{"label":"Salmeterol / Fluticasone propionate","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of the study is to compare the efficacy, safety and tolerability of aclidinium bromide/formoterol fumarate and salmeterol/fluticasone propionate in patients with chronic obstructive pulmonary disease (COPD)","primaryOutcome":{"measure":"Peak Forced Expiratory Volume in One Second (FEV1) at Week 24","timeFrame":"At Week 24","effectByArm":[{"arm":"Aclidinium Bromide / Formoterol Fumarate","deltaMin":1.655,"sd":0.011},{"arm":"Salmeterol / Fluticasone","deltaMin":1.562,"sd":0.011}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"40 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":20},"locations":{"siteCount":126,"countries":["Austria","Bulgaria","Canada","Czechia","France","Germany","Hungary","Italy","Lithuania","Netherlands","Poland","South Africa","Spain","United Kingdom"]},"refs":{"pmids":["27492833"],"seeAlso":["http://filehosting.pharmacm.com/DownloadService.ashx?client=CTR_MED_7111&studyid=3947&filename=LAC39_CSR_Synopsis.pdf"]},"adverseEventsSummary":{"seriousAny":{"events":35,"n":467},"commonTop":["Chronic obstructive pulmonary disease","Headache","Nasopharyngitis"]}}